Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rep-Pharm is a Belarusian pharmaceutical company dedicated to the development and manufacturing of high-quality generic medications. Founded in 2011, the company operates a modern production site in the Smolevichi district of the Minsk region, which adheres to international Good Manufacturing Practice (GMP) standards. Its diverse product portfolio covers critical therapeutic areas, including cardiovascular diseases, neurology, gastroenterology, and infectious diseases. Rep-Pharm focuses on providing affordable healthcare solutions and reducing reliance on imported pharmaceuticals within the Eurasian Economic Union. The company maintains a robust quality control system to ensure the safety and efficacy of its products throughout their lifecycle.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rep-Pharm.